Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

August 15, 2028

Study Completion Date

August 15, 2030

Conditions
Bladder (Urothelial, Transitional Cell) CancerBladder Cancer Requiring CystectomyBladder CarcinomaBladder NeoplasmMuscle Invasive Bladder Cancer (MIBC)
Interventions
DIAGNOSTIC_TEST

multiparametric magnetic resonance imaging (mpMRI) of the bladder

"This study will investigate the role of bladder mpMRI as a tool to expedite treatment in patients with muscle invasive bladder cancer.~mpMRIs will be investigated as a possible replacement of standard TURBt, a planned surgical procedure for cancer local staging.~mpMRis will be reported according to the Vesical Imaging - Reporting and Data System Stanrdars (VI-RADS) to provide a score indicating probability of muscle invasion."

PROCEDURE

Transurethral resection of bladder tumour (TURBt)

This is a planned endoscopic surgical procedure consisting in resection of the bladder tumour through a electrified loop manouvred with an endoscope. In muscle invasive bladder cancer, this procedure allows histological confirmation of presence of detrusor muscle invasion.

GENETIC

Circulating tumour DNA levels assessment

"Blood samples will be collected from each enrolled patient at pre-planned time points:~1. Cystoscopy, both arms~2. mpMRI (experimental arm) or TURBt (control arm)~3. Definite cancer treatment, both arms~ctDNA levels will be measured on the collected blood samples."

Trial Locations (1)

00133

RECRUITING

Policlinico Tor Vergata, Rome

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER

NCT07067749 - Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter